Annual FCF
$115.45 M
-$47.41 M-29.11%
31 March 2024
Summary:
Haemonetics annual free cash flow is currently $115.45 million, with the most recent change of -$47.41 million (-29.11%) on 31 March 2024. During the last 3 years, it has risen by +$43.69 million (+60.88%). HAE annual FCF is now -29.11% below its all-time high of $162.87 million, reached on 01 March 2023.HAE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$39.39 M
+$72.47 M+219.09%
28 September 2024
Summary:
Haemonetics quarterly free cash flow is currently $39.39 million, with the most recent change of +$72.47 million (+219.09%) on 28 September 2024. Over the past year, it has dropped by -$50.62 million (-56.24%). HAE quarterly FCF is now -56.24% below its all-time high of $90.01 million, reached on 30 September 2023.HAE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$20.35 M
-$50.62 M-71.32%
28 September 2024
Summary:
Haemonetics TTM free cash flow is currently $20.35 million, with the most recent change of -$50.62 million (-71.32%) on 28 September 2024. Over the past year, it has dropped by -$196.32 million (-90.61%). HAE TTM FCF is now -90.61% below its all-time high of $216.68 million, reached on 30 September 2023.HAE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -29.1% | -56.2% | -90.6% |
3 y3 years | +60.9% | +10.1% | -37.8% |
5 y5 years | +186.3% | +92.8% | -59.8% |
HAE Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -29.1% | +60.9% | -56.2% | +197.6% | -90.6% | at low |
5 y | 5 years | -29.1% | +186.3% | -56.2% | +197.6% | -90.6% | at low |
alltime | all time | -29.1% | +1341.5% | -56.2% | +197.6% | -90.6% | +199.8% |
Haemonetics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $39.39 M(-219.1%) | $20.35 M(-71.3%) |
June 2024 | - | -$33.08 M(-160.8%) | $70.97 M(-38.5%) |
Mar 2024 | $115.45 M(-29.1%) | - | - |
Mar 2024 | - | $54.40 M(-234.8%) | $115.45 M(-10.3%) |
Dec 2023 | - | -$40.36 M(-144.8%) | $128.75 M(-40.6%) |
Sept 2023 | - | $90.01 M(+689.2%) | $216.68 M(+21.9%) |
June 2023 | - | $11.40 M(-83.2%) | $177.75 M(+9.1%) |
Mar 2023 | $162.87 M(+115.0%) | $67.69 M(+42.3%) | $162.87 M(+27.1%) |
Dec 2022 | - | $47.57 M(-6.9%) | $128.11 M(+10.1%) |
Sept 2022 | - | $51.08 M(-1570.4%) | $116.31 M(+32.4%) |
June 2022 | - | -$3.47 M(-110.5%) | $87.88 M(+16.0%) |
Mar 2022 | $75.75 M(+5.6%) | $32.94 M(-7.9%) | $75.75 M(+131.4%) |
Dec 2021 | - | $35.77 M(+57.9%) | $32.73 M(-39.2%) |
Sept 2021 | - | $22.65 M(-245.2%) | $53.88 M(+3.5%) |
June 2021 | - | -$15.60 M(+54.7%) | $52.05 M(-27.5%) |
Mar 2021 | $71.77 M(-34.4%) | -$10.09 M(-117.7%) | $71.77 M(-39.0%) |
Dec 2020 | - | $56.92 M(+173.4%) | $117.61 M(-1.7%) |
Sept 2020 | - | $20.82 M(+405.7%) | $119.58 M(+0.3%) |
June 2020 | - | $4.12 M(-88.5%) | $119.20 M(+8.9%) |
Mar 2020 | $109.46 M(+171.5%) | $35.76 M(-39.3%) | $109.46 M(+35.8%) |
Dec 2019 | - | $58.89 M(+188.3%) | $80.62 M(+59.2%) |
Sept 2019 | - | $20.43 M(-463.4%) | $50.65 M(+29.6%) |
June 2019 | - | -$5.62 M(-181.2%) | $39.09 M(-3.0%) |
Mar 2019 | $40.32 M(-72.3%) | $6.92 M(-76.1%) | $40.32 M(-43.9%) |
Dec 2018 | - | $28.92 M(+226.1%) | $71.92 M(-12.1%) |
Sept 2018 | - | $8.87 M(-301.9%) | $81.83 M(-29.7%) |
June 2018 | - | -$4.39 M(-111.4%) | $116.45 M(-20.0%) |
Mar 2018 | $145.55 M(+74.1%) | $38.52 M(-0.8%) | $145.55 M(+15.5%) |
Dec 2017 | - | $38.82 M(-10.7%) | $125.99 M(+2.0%) |
Sept 2017 | - | $43.50 M(+76.1%) | $123.47 M(+23.4%) |
June 2017 | - | $24.70 M(+30.3%) | $100.09 M(+19.7%) |
Mar 2017 | $83.60 M(+329.6%) | $18.96 M(-47.8%) | $83.60 M(-6.4%) |
Dec 2016 | - | $36.31 M(+80.5%) | $89.36 M(+46.1%) |
Sept 2016 | - | $20.12 M(+144.9%) | $61.16 M(+43.3%) |
June 2016 | - | $8.22 M(-66.8%) | $42.67 M(+119.3%) |
Mar 2016 | $19.46 M(+292.5%) | $24.72 M(+204.8%) | $19.46 M(-31.4%) |
Dec 2015 | - | $8.11 M(+398.5%) | $28.36 M(+62.2%) |
Sept 2015 | - | $1.63 M(-110.8%) | $17.48 M(+31.3%) |
June 2015 | - | -$15.00 M(-144.6%) | $13.31 M(+168.4%) |
Mar 2015 | $4.96 M(-92.5%) | $33.62 M(-1315.7%) | $4.96 M(-169.7%) |
Dec 2014 | - | -$2.77 M(+8.6%) | -$7.11 M(-128.0%) |
Sept 2014 | - | -$2.54 M(-89.1%) | $25.42 M(-39.8%) |
June 2014 | - | -$23.35 M(-208.4%) | $42.22 M(-35.9%) |
Mar 2014 | $65.88 M(+187.8%) | $21.54 M(-27.6%) | $65.88 M(+11.0%) |
Dec 2013 | - | $29.77 M(+108.9%) | $59.37 M(+55.0%) |
Sept 2013 | - | $14.25 M(+4496.8%) | $38.31 M(+23.2%) |
June 2013 | - | $310.00 K(-97.9%) | $31.08 M(+35.8%) |
Mar 2013 | $22.89 M(-63.2%) | $15.04 M(+72.6%) | $22.89 M(-10.5%) |
Dec 2012 | - | $8.71 M(+24.0%) | $25.58 M(-21.4%) |
Sept 2012 | - | $7.02 M(-189.0%) | $32.56 M(-16.3%) |
June 2012 | - | -$7.89 M(-144.5%) | $38.90 M(-37.4%) |
Mar 2012 | $62.12 M(-19.1%) | $17.74 M(+13.1%) | $62.12 M(-4.2%) |
Dec 2011 | - | $15.69 M(+17.4%) | $64.84 M(-24.0%) |
Sept 2011 | - | $13.37 M(-12.8%) | $85.28 M(-9.1%) |
June 2011 | - | $15.33 M(-25.1%) | $93.81 M(+22.2%) |
Mar 2011 | $76.79 M(+3.3%) | $20.46 M(-43.4%) | $76.79 M(-5.9%) |
Dec 2010 | - | $36.13 M(+65.0%) | $81.59 M(+23.7%) |
Sept 2010 | - | $21.90 M(-1389.5%) | $65.96 M(-3.2%) |
June 2010 | - | -$1.70 M(-106.7%) | $68.16 M(-8.3%) |
Mar 2010 | $74.36 M(+24.0%) | $25.26 M(+23.2%) | $74.36 M(-9.4%) |
Dec 2009 | - | $20.51 M(-14.9%) | $82.10 M(+8.6%) |
Sept 2009 | - | $24.10 M(+435.3%) | $75.58 M(+19.9%) |
June 2009 | - | $4.50 M(-86.4%) | $63.04 M(+5.1%) |
Mar 2009 | $59.98 M(+201.8%) | $33.00 M(+135.9%) | $59.98 M(+37.5%) |
Dec 2008 | - | $13.99 M(+21.0%) | $43.61 M(+11.1%) |
Sept 2008 | - | $11.55 M(+698.5%) | $39.26 M(+111.1%) |
June 2008 | - | $1.45 M(-91.3%) | $18.59 M(-6.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | $19.88 M(-52.8%) | $16.62 M(+72.5%) | $19.88 M(+54.3%) |
Dec 2007 | - | $9.63 M(-205.8%) | $12.88 M(-34.0%) |
Sept 2007 | - | -$9.11 M(-433.3%) | $19.52 M(-48.1%) |
June 2007 | - | $2.73 M(-71.6%) | $37.64 M(-10.6%) |
Mar 2007 | $42.10 M(-13.8%) | $9.62 M(-40.9%) | $42.10 M(-10.8%) |
Dec 2006 | - | $16.27 M(+80.7%) | $47.21 M(-10.8%) |
Sept 2006 | - | $9.01 M(+25.1%) | $52.95 M(+4.3%) |
June 2006 | - | $7.20 M(-51.1%) | $50.76 M(+3.9%) |
Mar 2006 | $48.84 M(-9.0%) | $14.73 M(-33.1%) | $48.84 M(-6.6%) |
Dec 2005 | - | $22.01 M(+223.1%) | $52.30 M(+14.8%) |
Sept 2005 | - | $6.81 M(+29.0%) | $45.57 M(-14.4%) |
June 2005 | - | $5.28 M(-71.0%) | $53.26 M(-0.8%) |
Mar 2005 | $53.68 M(-14.7%) | $18.19 M(+19.1%) | $53.68 M(-7.7%) |
Dec 2004 | - | $15.28 M(+5.3%) | $58.17 M(-14.0%) |
Sept 2004 | - | $14.51 M(+154.4%) | $67.61 M(-2.2%) |
June 2004 | - | $5.70 M(-74.9%) | $69.15 M(+9.9%) |
Mar 2004 | $62.91 M(+107.9%) | $22.69 M(-8.2%) | $62.91 M(+25.1%) |
Dec 2003 | - | $24.71 M(+54.1%) | $50.28 M(+36.3%) |
Sept 2003 | - | $16.04 M(-3092.7%) | $36.88 M(+18.1%) |
June 2003 | - | -$536.00 K(-105.3%) | $31.22 M(+3.2%) |
Mar 2003 | $30.26 M(+184.5%) | $10.07 M(-11.0%) | $30.26 M(-3.1%) |
Dec 2002 | - | $11.31 M(+9.0%) | $31.23 M(+117.0%) |
Sept 2002 | - | $10.38 M(-794.7%) | $14.39 M(+36.3%) |
June 2002 | - | -$1.49 M(-113.5%) | $10.55 M(-0.8%) |
Mar 2002 | $10.64 M(-73.8%) | $11.03 M(-299.6%) | $10.64 M(-32.4%) |
Dec 2001 | - | -$5.53 M(-184.4%) | $15.73 M(-42.4%) |
Sept 2001 | - | $6.54 M(-563.2%) | $27.29 M(-28.2%) |
June 2001 | - | -$1.41 M(-108.8%) | $38.00 M(-6.6%) |
Mar 2001 | $40.67 M(+34.9%) | $16.12 M(+167.0%) | $40.67 M(-13.8%) |
Dec 2000 | - | $6.04 M(-65.0%) | $47.20 M(+26.0%) |
Sept 2000 | - | $17.26 M(+1275.0%) | $37.46 M(+20.0%) |
June 2000 | - | $1.25 M(-94.5%) | $31.20 M(+3.5%) |
Mar 2000 | $30.15 M(+168.0%) | $22.65 M(-712.2%) | $30.15 M(+38.6%) |
Dec 1999 | - | -$3.70 M(-133.6%) | $21.75 M(+68.0%) |
Sept 1999 | - | $11.00 M(+5400.0%) | $12.95 M(+197.8%) |
June 1999 | - | $200.00 K(-98.6%) | $4.35 M(-61.3%) |
Mar 1999 | $11.25 M(>+9900.0%) | $14.25 M(-214.0%) | $11.25 M(-60.7%) |
Dec 1998 | - | -$12.50 M(-620.8%) | $28.60 M(-20.6%) |
Sept 1998 | - | $2.40 M(-66.2%) | $36.00 M(+71.4%) |
June 1998 | - | $7.10 M(-77.5%) | $21.00 M(>+9900.0%) |
Mar 1998 | $0.00(-100.0%) | $31.60 M(-719.6%) | $0.00(-100.0%) |
Dec 1997 | - | -$5.10 M(-59.5%) | -$20.40 M(+121.7%) |
Sept 1997 | - | -$12.60 M(-9.4%) | -$9.20 M(+1433.3%) |
June 1997 | - | -$13.90 M(-224.1%) | -$600.00 K(-105.9%) |
Mar 1997 | $10.20 M(-70.9%) | $11.20 M(+83.6%) | $10.20 M(+32.5%) |
Dec 1996 | - | $6.10 M(-252.5%) | $7.70 M(-34.2%) |
Sept 1996 | - | -$4.00 M(+29.0%) | $11.70 M(-59.9%) |
June 1996 | - | -$3.10 M(-135.6%) | $29.20 M(-16.8%) |
Mar 1996 | $35.10 M(-477.4%) | $8.70 M(-13.9%) | $35.10 M(+19.0%) |
Dec 1995 | - | $10.10 M(-25.2%) | $29.50 M(+76.6%) |
Sept 1995 | - | $13.50 M(+382.1%) | $16.70 M(+1184.6%) |
June 1995 | - | $2.80 M(-9.7%) | $1.30 M(-114.0%) |
Mar 1995 | -$9.30 M(-326.8%) | $3.10 M(-214.8%) | -$9.30 M(-10.6%) |
Dec 1994 | - | -$2.70 M(+42.1%) | -$10.40 M(+1980.0%) |
Sept 1994 | - | -$1.90 M(-75.6%) | -$500.00 K(-118.5%) |
June 1994 | - | -$7.80 M(-490.0%) | $2.70 M(-34.1%) |
Mar 1994 | $4.10 M(-77.6%) | $2.00 M(-72.2%) | $4.10 M(-21.2%) |
Dec 1993 | - | $7.20 M(+453.8%) | $5.20 M(-22.4%) |
Sept 1993 | - | $1.30 M(-120.3%) | $6.70 M(-49.2%) |
June 1993 | - | -$6.40 M(-306.5%) | $13.20 M(-27.9%) |
Mar 1993 | $18.30 M(+147.3%) | $3.10 M(-64.4%) | $18.30 M(-34.2%) |
Dec 1992 | - | $8.70 M(+11.5%) | $27.80 M(+104.4%) |
Sept 1992 | - | $7.80 M(-700.0%) | $13.60 M(+231.7%) |
June 1992 | - | -$1.30 M(-110.3%) | $4.10 M(-44.6%) |
Mar 1992 | $7.40 M | $12.60 M(-329.1%) | $7.40 M(-242.3%) |
Dec 1991 | - | -$5.50 M(+223.5%) | -$5.20 M(-1833.3%) |
Sept 1991 | - | -$1.70 M(-185.0%) | $300.00 K(-85.0%) |
June 1991 | - | $2.00 M | $2.00 M |
FAQ
- What is Haemonetics annual free cash flow?
- What is the all time high annual FCF for Haemonetics?
- What is Haemonetics annual FCF year-on-year change?
- What is Haemonetics quarterly free cash flow?
- What is the all time high quarterly FCF for Haemonetics?
- What is Haemonetics quarterly FCF year-on-year change?
- What is Haemonetics TTM free cash flow?
- What is the all time high TTM FCF for Haemonetics?
- What is Haemonetics TTM FCF year-on-year change?
What is Haemonetics annual free cash flow?
The current annual FCF of HAE is $115.45 M
What is the all time high annual FCF for Haemonetics?
Haemonetics all-time high annual free cash flow is $162.87 M
What is Haemonetics annual FCF year-on-year change?
Over the past year, HAE annual free cash flow has changed by -$47.41 M (-29.11%)
What is Haemonetics quarterly free cash flow?
The current quarterly FCF of HAE is $39.39 M
What is the all time high quarterly FCF for Haemonetics?
Haemonetics all-time high quarterly free cash flow is $90.01 M
What is Haemonetics quarterly FCF year-on-year change?
Over the past year, HAE quarterly free cash flow has changed by -$50.62 M (-56.24%)
What is Haemonetics TTM free cash flow?
The current TTM FCF of HAE is $20.35 M
What is the all time high TTM FCF for Haemonetics?
Haemonetics all-time high TTM free cash flow is $216.68 M
What is Haemonetics TTM FCF year-on-year change?
Over the past year, HAE TTM free cash flow has changed by -$196.32 M (-90.61%)